As of 2025-10-14, the Fair Value of Pacific Biosciences of California Inc (PACB) is -8.76 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.62 USD, the upside of Pacific Biosciences of California Inc is -640.85%.
With the market price of 1.62 USD and our fair value calculation, Pacific Biosciences of California Inc (PACB) is not a good investment. Investing in PACB stocks now will result in a potential loss of 640.85%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 29.40 | -181.20 | -314.20 | -306.74 | -309.85 | -216.52 |
| YoY growth | 134.96% | -716.33% | -73.40% | 2.38% | -1.02% | -130.68% |
| Market Cap (mil) | 486.60 |
| P/E | |
| Forward P/E |
| EPS | -1.75 |
| Avg earnings growth rate | -130.68% |
| TTM earnings | -526.36 |